- Home
- DHC vs ALMR Comparison
DHC vs ALMR Comparison
Compare DHC & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHC | ALMR |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 1998 | 2026 |
Fundamental Metrics
Financial Performance| Metric | DHC | ALMR |
|---|---|---|
| Price | $7.43 | $29.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 337.3K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | ★ 23.23 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,074,819,000.00 | N/A |
| Revenue This Year | $3.13 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $3.93 | $21.58 |
| 52 Week High | $9.66 | $38.54 |
Technical Indicators
Market Signals| Indicator | DHC | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 29.99 | 45.19 |
| Support Level | $6.92 | $29.15 |
| Resistance Level | $7.59 | $35.74 |
| Average True Range (ATR) | 0.24 | 1.91 |
| MACD | -0.01 | -0.63 |
| Stochastic Oscillator | 1.79 | 0.22 |
Price Performance
Historical ComparisonAbout DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
About ALMR Alamar Biosciences Inc. Common Stock
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.